NCT01311440

Brief Summary

In Oslo University Hospital, department of complex epilepsy, offer ketogenic diet to treat children with medically intractable epilepsy. From 2009 we added modified Atkins diet as a treatment option for children up to 18 years. We now initiate an open, prospective, randomized and controlled study with the aim to test the efficacy of treatment with modified Atkins diet in adults with focal and generalized epilepsy diagnoses, in order to evaluate whether this treatment should be offered to patients on a permanent basis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

March 7, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 9, 2011

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

September 19, 2017

Status Verified

September 1, 2017

Enrollment Period

6.3 years

First QC Date

March 7, 2011

Last Update Submit

September 18, 2017

Conditions

Keywords

RCTmodified Atkins dietepilepsyadultsketogenic diet

Outcome Measures

Primary Outcomes (1)

  • Change in seizure frequency

    All participants record detailed seizure records for 12 weeks prior to the control/diet period. The diet group participants are subsequently treated with modified Atkins diet for 12 weeks, while the control group continue their normal diet and record seizures for another 12 weeks. Seizure records for each participant before and during intervention are compared.

    12 weeks

Secondary Outcomes (6)

  • Change in body weight

    12 weeks

  • Change in standard 3-hrs EEG

    12 weeks

  • Change in life quality measured by validated questionnaire

    12 weeks

  • Change in various blood and serum measures

    12 weeks

  • Change in executive functions measured with validated questionnaire

    12 weeks

  • +1 more secondary outcomes

Study Arms (2)

Modified Atkins diet treatment

EXPERIMENTAL

12 weeks of Modified Atkins diet treatment, recording seizures

Other: Modified Atkins diet treatment

No intervention

NO INTERVENTION

12 weeks seizure record

Interventions

Eat a diet containing 16 grams of carbohydrates per day, maximize on fat. Assure sufficient intake of micronutrients.

Modified Atkins diet treatment

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Focal or generalized epilepsy diagnosis
  • More than 3 recordable seizures per month
  • BMI \> 18,5
  • Not responded to at least three 3 AEDs
  • years or older
  • Motivated to complete the diet after thorough information
  • Capable of recording seizures
  • Capable of preparing the diet

You may not qualify if:

  • Hypercholesterolemia, cardiovascular disease or kidney disease
  • Been on modified Atkins diet for more than one week during the last year
  • Status epilepticus last six months
  • epilepsy surgery or VNS implant last year
  • weeks continuous seizure freedom last 2 months
  • PNES seizures
  • other disease where dietary treatment is contraindicated
  • usage of drugs or supplements that may interfere with diet or AED
  • being pregnant or planning pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital, The national Centre for epilepsy

Sandvika, Bærum Postterminal, 1306, Norway

Location

MeSH Terms

Conditions

EpilepsyEpilepsies, PartialEpilepsy, Generalized

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Karl Otto Nakken

    Oslo University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Registered Nutritionist

Study Record Dates

First Submitted

March 7, 2011

First Posted

March 9, 2011

Study Start

March 1, 2011

Primary Completion

June 1, 2017

Study Completion

July 1, 2017

Last Updated

September 19, 2017

Record last verified: 2017-09

Locations